🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Acute kidney injury(AKI) is a common, severe emergency case in clinics,espe...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2021-12-31
Trial ID
NCT04194671
Treatments Being Tested
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
The trial is designed as a multi-center, open label Phase 2 trial that inve...
Status
Completed
Location
3203; Antwerp University Hospital; Department of Medical Oncology
Start Date
2011-07
Trial ID
NCT01417936
Treatments Being Tested
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
The purpose of this study is to determine whether ATIR is safe and effectiv...
Status
Completed
Location
Algemeen Ziekenhuis Sint-Jan
Start Date
2013-03
Trial ID
NCT01794299
Treatments Being Tested
The study is an open-label Phase 1 single dose-escalation safety study of C...
Status
Completed
Location
Mayo Clinic Florida
Start Date
2018-10-15
Trial ID
NCT03464916
Treatments Being Tested
Considerable progress in the treatment of metastatic melanoma has been made...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2015-10
Trial ID
NCT02619058
Treatments Being Tested
The objective of this study is to assess the efficacy, safety of MRG003 as ...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2020-09-04
Trial ID
NCT04838548
Treatments Being Tested
This is a Phase I Clinical Trial. Phase I studies are designed to determine...
Status
Terminated
Location
University of Maryland Greenebaum Cancer Center
Start Date
2010-04-27
Trial ID
NCT01110226